Companies: 10,795·Total market cap: $144.5T
LeMaitre Vascular, Inc.

LeMaitre Vascular, Inc.

LMATNASDAQHealthcare● Active
$95.11
+$0.63(+0.67%)
Market Cap$2.2B
P/E Ratio
52W High$118.01
52W Low$79.01

LeMaitre Vascular, Inc. (LMAT) Cash on Hand — Cash & Short-Term Investments

Cash & cash equivalents plus short-term investments from the balance sheet, YoY change, and net cash vs debt context.

LMAT · cash on hand · updated Dec 31, 2025

Core cash position

Cash & Short-Term Investments (CCE + ST Investments)
$359.1M +19.8% vs prior year
FY · as of Dec 31, 2025 · Reported in USD
Cash & Cash Equiv. (CCE)
$28.2M
cashAndCashEquivalents
Short-Term Investments
$330.9M
shortTermInvestments
YoY Change vs Prior Year
+19.8%
vs prior fiscal year
Latest Quarter
$367.2M
Q1 2026
Data Scope & Methodology

Cash on Hand = Cash & Cash Equivalents (CCE) + Short-Term Investments, as reported on the balance sheet (10-K/10-Q). Also referred to as cash reserves or cash position. Not free cash flow.

Source: FMP /balance-sheet-statement · SEC 10-K / 10-Q · Reported in USD

Source: FMP /balance-sheet-statement · SEC 10-K / 10-Q · USDUpdated: December 31, 2025

Net cash vs debt

Cash & ST Investments$359.1MCash on Hand
Total Debt$185.6MTotal Debt
Net Cash / Net Debt+$173.5MNet Cash Position
Cash vs Debt Ratio
Cash 66%Debt 34%

LeMaitre Vascular, Inc. has a net cash position of $173.5M, holding more cash than debt.

Net Cash = Cash & ST Investments − Total Debt$359.1M$185.6M = +$173.5M

Cash on hand history

YoY Increase
YoY Decrease
Latest Year
LMAT annual cash on hand history · Cash & Short-Term Investments · Source: FMP /balance-sheet-statement

Annual cash on hand by year

DateCash & ST InvestmentsYoY Change
Dec 31, 2025Latest$359.1M+19.8%
Dec 31, 2024$299.7M+185.2%
Dec 31, 2023$105.1M+27.1%
Dec 31, 2022$82.7M+18.2%
Dec 31, 2021$70.0M+159.3%
LMAT cash on hand annual historical data · Cash & Short-Term Investments per balance sheet (10-K/10-Q) · Reported in USD · Source: FMP /balance-sheet-statement

Healthcare Sector Cash Reserves Comparison

#CompanyCash & ST Inv.Cash/MCap
#1
UnitedHealth Group Incorporated
UnitedHealth Group Incorporated
UNH
$28.12B7.6%
#2
Johnson & Johnson
Johnson & Johnson
JNJ
$20.10B3.6%
#3
Eli Lilly and Company
Eli Lilly and Company
LLY
$7.27B0.7%
#4
AbbVie Inc.
AbbVie Inc.
ABBV
$5.26B1.3%
#5
LeMaitre Vascular, Inc.
LeMaitre Vascular, Inc.YOU
LMAT
$359.1M16.5%
Healthcare sector cash reserves · Source: FMP /balance-sheet-statement + /profile · Sorted by Cash desccompanies with most cash on hand →

About cash on hand & methodology

LeMaitre Vascular, Inc. (LMAT) cash on hand as of December 31, 2025 is $359.1M, comprising $28.2M in cash and cash equivalents (CCE) plus $330.9M in short-term investments — reported as LeMaitre Vascular, Inc. cash and short-term investments on the balance sheet (10-K filing). Also referred to as LeMaitre Vascular, Inc. cash reserves or cash position.

LeMaitre Vascular, Inc. annual cash on hand history shows increased +19.8% in 2025: increased +19.8% in 2025. LeMaitre Vascular, Inc. cash reserves in 2025 reflect the company's capital allocation strategy.

LeMaitre Vascular, Inc. carries total debt of $185.6M against cash of $359.1M, resulting in a net cash position of +$173.5M. For the full balance sheet, see the Financials → Balance Sheet tab.

Figures tie to SEC 10-K/10-Q balance sheet disclosures and FMP /balance-sheet-statement where noted.

Frequently asked questions

LMAT cash on hand · 5 questions

As of December 31, 2025, LeMaitre Vascular, Inc. (LMAT) has $359,120,000 in cash on hand — defined as cash and short-term investments on the balance sheet. This includes $28,244,000 in cash and cash equivalents (CCE) plus $330,876,000 in short-term investments. Latest quarter (March 31, 2026): $367,233,000. Data sourced from the annual 10-K filing via FMP.

LMAT cash on handLMAT cash reservesLMAT cash 2025how much cash does LMAT have

Source: FMP /balance-sheet-statement · US GAAP · LeMaitre Vascular, Inc. · LeMaitre Vascular, Inc. SEC 10-K & 10-Q filings · US GAAP · Last updated: December 31, 2025